🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A phase 3, randomized, double-blind trial to evaluate the safety and immuno...
Status
Completed
Location
Seishinkai Inoue Hospital
Start Date
2021-06-14
Trial ID
NCT04875533
The objective of the study is to evaluate the safety, tolerability, and imm...
Status
Active Not Recruiting
Location
The Children's Clinic of Jonesboro, P.A
Start Date
2024-11-25
Trial ID
NCT06720038
The study will evaluate the safety, tolerability, and immunogenicity of VAX...
Status
Active Not Recruiting
Location
Chinle Center for Indigenous Health
Start Date
2026-02-09
Trial ID
NCT07425392
Treatments Being Tested
The purpose of this study is to learn about the safety of a new pneumococca...
Status
Active Not Recruiting
Location
Northwest Arkansas Pediatric Clinic
Start Date
2024-07-25
Trial ID
NCT06524414
The purpose of this study is to learn about the safety of a new pneumococca...
Status
Recruiting
Location
Alabama Clinical Therapeutics, LLC Birmingham Pediatric Associates
Start Date
2026-06-15
Trial ID
NCT07660198
Treatments Being Tested
This study is designed to 1) describe the safety, tolerability, and immunog...
Status
Completed
Location
Bliss Healthcare Services ( Site 0010)
Start Date
2018-07-06
Trial ID
NCT03480802
Treatments Being Tested
In the treatment of pneumococcal diseases, the common use of penicillin-bas...
Status
Completed
Location
Jiangsu Provincial Center for Diseases Control and Prevention
Start Date
2023-11-18
Trial ID
NCT07025876
Treatments Being Tested
The purpose of this study is to learn about the safety of a new pneumococca...
Status
Recruiting
Location
Alabama Clinical Therapeutics, LLC Birmingham Pediatric Associates
Start Date
2026-05-29
Trial ID
NCT07629440
Treatments Being Tested
This is a phase 3, randomized, double-blind, active comparator-controlled s...
Status
Completed
Location
Central Research Associates ( Site 0067)
Start Date
2022-07-13
Trial ID
NCT05425732
This is a phase 3 randomized, modified double-blind study whose purpose is ...
Status
Recruiting
Location
Northwest Arkansas Pediatric Clinic- Site Number : 8400039
Start Date
2026-01-20
Trial ID
NCT07348692
Treatments Being Tested